This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Sassa S. Modern diagnosis and management of the porphyrias. British Journal of Haematology, 2006; 135: 281–292SassaS.Modern diagnosis and management of the porphyriasBritish Journal of Haematology200613528129210.1111/j.1365-2141.2006.06289.x16956347Search in Google Scholar
Mehta M., Rath G.P., Padhy U.P., Marda M., Mahajan C. and Dash H.D. Intensive care management of patients with acute intermittent porphyria: clinical report of four cases and review of literature. Indian J Crit Care Med. 2010; 14(2): 88–91.MehtaM.RathG.P.PadhyU.P.MardaM.MahajanC.DashH.D.Intensive care management of patients with acute intermittent porphyria: clinical report of four cases and review of literatureIndian J Crit Care Med2010142889110.4103/0972-5229.68222293673820859493Search in Google Scholar
Handschin, C., Lin, J., Rhee, J., et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell, 2005;122: 505–515.HandschinC.LinJ.RheeJ.Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alphaCell200512250551510.1016/j.cell.2005.06.04016122419Search in Google Scholar
Innala E., Andersson C. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. Journal of Internal Medicine. 2011; 269(5):538–545InnalaE.AnderssonC.Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern SwedenJournal of Internal Medicine2011269553854510.1111/j.1365-2796.2010.02335.x21198994Search in Google Scholar
Stölzel U., Stauch T., Doss M.O. Porphyrias. Internist (Berl). 2010; 51(12): 1525–33StölzelU.StauchT.DossM.O.PorphyriasInternist (Berl)2010511215253310.1007/978-3-642-04519-6_30Search in Google Scholar
Kovačević Z., Janićijević Petrovic M., Šarenac T., Mladenović V., Stojilković T. Acute intermittent Porphyria. PONS Med J. 2012; 9 (3):110–113.KovačevićZ.Janićijević PetrovicM.ŠarenacT.MladenovićV.StojilkovićT.Acute intermittent PorphyriaPONS Med J20129311011310.5937/pons1203110KSearch in Google Scholar
Balwani M., Desnick R.J. The porphyrias: advances in diagnosis and treatment. Hematology 2012;120: 19–27BalwaniM.DesnickR.J.The porphyrias: advances in diagnosis and treatmentHematology2012120192710.1182/asheducation.V2012.1.19.3795678Search in Google Scholar
Anderson K.E., Bloomer J.R., Bonkovsky H.L., et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005 Mar 15;142(6):439–50.AndersonK.E.BloomerJ.R.BonkovskyH.L.Recommendations for the diagnosis and treatment of the acute porphyriasAnn Intern Med2005Mar1514264395010.7326/0003-4819-142-6-200503150-0001015767622Search in Google Scholar
Sardh E., Harper P., Andersson D.E., Floderus Y. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Eur J Intern Med. 2009 Mar;20(2):201–7.SardhE.HarperP.AnderssonD.E.FloderusY.Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacksEur J Intern Med2009Mar202201710.1016/j.ejim.2008.06.01219327613Search in Google Scholar
Harper P., Wahlin S. Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria. Curr Treat Options Gastroenterol. 2007 Dec;10(6):444–55.HarperP.WahlinS.Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyriaCurr Treat Options Gastroenterol2007Dec1064445510.1007/s11938-007-0044-918221605Search in Google Scholar
González-Arriaza H.L., Bostwick J.M. Acute Porphyrias: A Case Report and Review. Am J Psychiatry 2003; 160 (3):450–8.González-ArriazaH.L.BostwickJ.M.Acute Porphyrias: A Case Report and ReviewAm J Psychiatry20031603450810.1176/appi.ajp.160.3.450Search in Google Scholar
Puy H., Gouya L., Deybach J.C. Porphyrias. Lancet. 2010 Mar.13;375(9718): 924–37.PuyH.GouyaL.DeybachJ.C.PorphyriasLancet2010Mar.1337597189243710.1016/S0140-6736(09)61925-5Search in Google Scholar
Jose J, Saravu K, Shastry B A, Jimmy B. Drug use in porphyria: a therapeutic dilemma. Singapore Med J 2008; 49(10): e272–e275JoseJSaravuKShastryB AJimmyBDrug use in porphyria: a therapeutic dilemmaSingapore Med J20084910e272e275Search in Google Scholar
Andersson C., Lithner F. Hypertension and renal disease in patients with acute intermittent porphyria. Journal of Internal Medicine. 1994; 236(2):169–175AnderssonC.LithnerF.Hypertension and renal disease in patients with acute intermittent porphyriaJournal of Internal Medicine1994236216917510.1111/j.1365-2796.1994.tb01279.xSearch in Google Scholar
Singh V., Sud K., Kohli H.S., Gupta K.L., Sakhuja V. Acute Intermittent Porphyria : An Unusual Cause of Malignant Hypertension. JAPI. 2003; (51): 225–226.SinghV.SudK.KohliH.S.GuptaK.L.SakhujaV.Acute Intermittent Porphyria : An Unusual Cause of Malignant HypertensionJAPI200351225226Search in Google Scholar
Cinemre H, Korkmaz U, Alcelik A, Onder E, Gungor A. Safety of amlodipine use in patients with acute intermittent porphyria. Br J Clin Pharmacol 2007;64(2): 246–247CinemreHKorkmazUAlcelikAOnderEGungorASafety of amlodipine use in patients with acute intermittent porphyriaBr J Clin Pharmacol200764224624710.1111/j.1365-2125.2007.02906.xSearch in Google Scholar
Lambrecht R.W., Gildemeister O.S., Williams A., Pepe J.A., Tortorelli K.D., Bonkovsky H.L. Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation: implications for clinical porphyria. Biochem Pharmacol. 1999 Sep 1;58(5):887–96LambrechtR.W.GildemeisterO.S.WilliamsA.PepeJ.A.TortorelliK.D.BonkovskyH.L.Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation: implications for clinical porphyriaBiochem Pharmacol1999Sep15858879610.1016/S0006-2952(99)00154-9Search in Google Scholar
